Swine flu poses a real threat, but right now officials and an anxious public are short on good info.
April 26th, 2009 | Uncategorized | Comments Off
Novartis has ambitious plans for its new kidney cancer drug.
April 23rd, 2009 | Uncategorized | Comments Off
This year, pharmaceuticals could see the worst sales growth of the past quarter century.
April 22nd, 2009 | Uncategorized | Comments Off
Roche overpaid for Genentech. The question is by how much.
April 22nd, 2009 | Uncategorized | Comments Off
Quarterly numbers show why Merck decided, after years of merger aversion, to buy Schering-Plough.
April 21st, 2009 | Uncategorized | Comments Off